Pivotal Therapeutics Inc. announced changes to its Board designed to increase its independence and enhance Pivotal's corporate governance at this stage of the Company's development. Dr. Jackowski has stepped down as Chairman of Pivotal Therapeutics Inc. effective May 13, 2014 but remains a director and the Chief Scientific Officer of the Company and will continue to leverage his wealth of experience and contacts in the biotechnology and pharmaceutical industry to advance Pivotal's clinical, R&D and business development activities. John S. Gebhardt, an independent director of the Company, has been appointed as non-executive Chairman to fill the vacancy. A member of Pivotal's Board of Directors since 2011, Mr. Gebhardt
has over thirty years of experience in the financial and securities industry.